Role of Chinese Medicine Monomers in Dry Eye Disease: Breaking the Vicious Cycle of Inflammation
Zhuoyu Hu,
No information about this author
Xiangdong Chen,
No information about this author
Qi Hu
No information about this author
et al.
Pharmacology Research & Perspectives,
Journal Year:
2025,
Volume and Issue:
13(2)
Published: Feb. 20, 2025
Dry
eye
disease
(DED)
is
a
chronically
inflammatory
ocular
surface
disorder
of
unknown
pathogenesis.
Anti-inflammatory
medications,
artificial
tears,
autologous
serum,
and
LipiFlow
have
been
shown
to
be
highly
beneficial
in
alleviating
symptoms.
Nevertheless,
these
interventions
often
provide
only
short-term
results
do
not
address
the
underlying
problems
disease.
There
growing
evidence
that
risk
DED
associated
with
vicious
cycle
inflammation.
This
inflammation
produced
by
interaction
several
factors,
including
tear
film
hyperosmolarity,
instability,
inflammation,
apoptosis.
Chinese
medicine
monomers,
distinguished
their
multicomponent
multitarget
advantages,
help
treat
modulating
status,
inhibiting
responses,
apoptosis,
providing
new
way
thinking
management
medicine.
Language: Английский
Biased agonism of G protein-coupled receptors as a novel strategy for osteoarthritis therapy
Bone Research,
Journal Year:
2025,
Volume and Issue:
13(1)
Published: May 12, 2025
Abstract
Osteoarthritis
(OA)
is
a
prevalent
degenerative
joint
disorder
marked
by
chronic
pain,
inflammation,
and
cartilage
loss,
with
current
treatments
limited
to
symptom
relief.
G
protein-coupled
receptors
(GPCRs)
play
pivotal
role
in
OA
progression
regulating
chondrocyte
survival,
matrix
homeostasis.
However,
their
multifaceted
signaling,
via
proteins
or
β-arrestins,
poses
challenges
for
precise
therapeutic
targeting.
Biased
agonism,
where
ligands
selectively
activate
specific
GPCR
pathways,
emerges
as
promising
approach
optimize
efficacy
reduce
side
effects.
This
review
examines
biased
signaling
OA-associated
GPCRs,
including
cannabinoid
(CB
1
,
CB
2
),
chemokine
(CCR2,
CXCR4),
protease-activated
(PAR-2),
adenosine
(A
R,
A
2A
2B
3
R),
melanocortin
(MC
MC
bradykinin
(B
prostaglandin
E
(EP-2,
EP-4),
calcium-sensing
(CaSR).
We
analyze
clinical
trials
explore
natural
products
from
Traditional
Chinese
Medicine
potential
agonists.
These
compounds,
diverse
structures
bioactivities,
offer
novel
avenues.
By
harnessing
this
underscores
the
developing
targeted,
safer
therapies
that
address
its
complex
pathology,
bridging
molecular
insights
translation.
Language: Английский
Biological Evaluation of Lysionotin: a Novel Inhibitor of 5-Lipoxygenase for Anti-glioma
Xinxin Shao,
No information about this author
Cong Chen,
No information about this author
Jie Liu
No information about this author
et al.
Chinese Journal of Integrative Medicine,
Journal Year:
2024,
Volume and Issue:
30(9), P. 826 - 834
Published: July 11, 2024
Language: Английский
Identification of stable reference genes for quantitative real-time PCR in human fibroblasts from lymph nodes and synovium
Sajede Rasouli,
No information about this author
Chaja M. J. van Ansenwoude,
No information about this author
Johanna F. Semmelink
No information about this author
et al.
Published: July 12, 2024
Abstract
Real-time
quantitative
PCR
(RT–qPCR)
has
emerged
as
an
accurate
and
widely
used
technique
for
measuring
gene
expression
levels.
However,
its
reliability
depends
on
the
selection
of
appropriate
reference
genes
to
normalize
sample
input.
Accordingly,
identification
characterized
by
stable
in
cells
conditions
interest
is
essential
ensuring
values.
To
date,
no
study
specifically
identified
suitable
primary
human
cultured
fibroblast-like
synoviocytes
(FLS)
lymph
node
stromal
(LNSCs)
within
context
rheumatoid
arthritis
(RA).
These
play
a
critical
role
pathogenesis
disease.
In
this
study,
we
evaluated
suitability
15
candidate
normalizing
transcript
FLS
LNSCs
subjected
various
vitro
stimuli.
We
included
traditional
often
normalization
fibroblasts
well
via
GeneVestigator
analysis
publicly
available
transcriptomic
data.
RefFinder
algorithms
were
identify
most
across
cell
types
different
experimental
conditions.
determined
that
optimal
number
every
condition
tested
was
two;
RPLP0
POLR2G
exhibited
greatest
stability
LNSCs.
FLS,
observed
greater
variability
Although
TBP
under
unstimulated
conditions,
our
findings
indicated
require
distinct
depending
specific
Validation
selected
levels
metabolic
emphasized
importance
prior
evaluation
potential
genes,
arbitrary
could
lead
data
misinterpretation.
This
constitutes
first
systematic
selecting
fibroblasts.
Our
emphasize
proper
each
separately
when
applying
standard
technology
assessing
Language: Английский
Advances in understanding the role of interleukins in pulmonary fibrosis (Review)
Yuqing He,
No information about this author
Xuebin Shen,
No information about this author
Kefeng Zhai
No information about this author
et al.
Experimental and Therapeutic Medicine,
Journal Year:
2024,
Volume and Issue:
29(2)
Published: Nov. 28, 2024
Pulmonary
fibrosis
(PF)
is
a
progressive,
irreversible
disease
characterized
by
heterogeneous
interstitial
lung
tissue
damage.
It
originates
from
persistent
or
repeated
epithelial
injury
and
leads
to
the
activation
differentiation
of
fibroblasts
into
myofibroblasts.
Interleukins
(ILs)
are
group
lymphokines
crucial
for
immunomodulation
that
implicated
in
pathogenesis
PF.
However,
different
types
ILs
exert
disparate
effects
on
In
present
review,
based
effect
PF,
classified
three
categories:
i)
Promotors
PF;
ii)
inhibitors
iii)
those
dual
Several
can
promote
PF
provoking
inflammation,
initiating
proliferation
transdifferentiation
cells,
exacerbating
injury,
while
other
inhibit
through
suppressing
expression
inflammatory
factors,
modulating
Th1/Th2
balance
autophagy.
The
review
summarizes
association
focusing
roles
mechanisms
underlying
Language: Английский